Press Release InnoCare Reports 2026 Interim Results, Sustained Profitability and Key Milestones Achieved 7 hours ago
Press Release InnoCare Announces Approval of Head-to-Head Registrational Phase III Trial of Mesutoclax with Azacitidine versus Venetoclax with Azacitidine in Treatment-Naive AML in China Aug 18